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ABSTRACT.
Background: Malaria is a public health problem globally especially in the Sub-Saharan Africa and among 
the under five children and pregnant women. Malaria in pregnancy is well known to be associated with a lot 
of maternal and fetal complications. Intermittent Preventive Treatment with Sulphadoxine-Pyrimethamine 
is the currently recommended regimen for prevention of malaria in pregnancy in the endemic areas.
Objective: The study was on the effect of intermittent preventive treatment of malaria in pregnancy on the 
prevalence of malaria in pregnancy and the outcome of pregnancy.
Method: It was a prospective descriptive cross-sectional study and a semi-structured questionnaire was 
administered to women in the lying in ward University Teaching Hospital, Ado-Ekiti, who booked in the 
hospital, attended at least two antenatal clinic visits and delivered in the hospital.
Results: The study revealed that about 75% of the pregnant women studied had access to intermittent 
preventive treatment of malaria and also that among the women attending the antenatal clinic that received 
the IPT, about 78% of them took the recommended dose of the IPT. The prevalence of malaria was 
statistically higher in women who did not receive intermittent preventive treatment with sulphadoxine-
pyrimethamine during pregnancy (44.7% vs 31.3%, p=0.0001) and among women who had one dose of the 
drug instead of two doses (40.0% vs 28.7%, p= 0.0001). There was no statistical significant difference in the 
mean age in years (31.53±5.238 vs 31.07±4.751, p= 0.09 and the gestational age at delivery (38.76±1.784 vs 
38.85±1.459, p= 0.122) between the women who did not receive IPT and those who had it.
There was a statistical significant difference in the outcome of pregnancy among women who had IPT and 
those who did not viz a viz in the duration of labor (8.6±1.491 vs 8.7 ± 1.634, p= 0.011) and the birth weight 
of the babies (3.138 ±0.402 vs 3.263± 0.398, p=0.0001)
Conclusion: Intermittent preventive of malaria with Sulphadoxine-pyrimethamine in pregnancy is 
effective as a prophylaxis against malaria and improves the outcome of pregnancy in malaria's endemic 
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INTRODUCTION
Malaria is an important public health 
problem globally and especially in Sub-
Saharan Africa due to climatic factors, poor 
environmental sanitation and cultural habits 
which provide conducive atmosphere that 
allows transmission of the parasite throughout 
1
the year . It has been estimated that about 90% 
of the annual 500 million cases of malaria occur 
in the Sub-Saharan Africa with 80% of the 1.5-
1
3.0 million annual deaths due to malaria . Most 
studies from Sub-Saharan Africa showed that 
about 25 million pregnant women are at risk of 
2
malaria infection every year  while it is 
estimated that 40% of the world's pregnant 
women are exposed to malaria infection during 
3
pregnancy .
In Nigeria, at least 50% of the population 
has malaria infection annually with under-five 
children and pregnant women at greater risk of 
3
the debilitating effects of the infection . Malaria 
accounts for 30% of childhood mortality and 
11% of maternal deaths in Nigeria. In many 
African countries, malaria is holo-endemic and 
non-pregnant female adults have a significant 
level of immunity against malaria. However, 
during pregnancy, these women experience a 
considerable decline in their levels of immunity 
4
to malaria  and several studies have reported 
st nd
that 1  and 2  pregnancies are associated with a 
higher prevalence of malaria in the first half of 
pregnancy in women living in endemic 
5-7
malarious areas .
Malaria is an important cause of 
maternal anemia, intrauterine growth 
retardation, intrauterine death, still birth, 
premature delivery, low birth weight(LBW), 
perinatal and neonatal morbidity and mortality 
4,8,9
and post-partum morbidity . In Sub-Saharan 
Africa, poor nutrition, micronutrient 
imbalances (especially vitamin A, Zinc, Iron and 
Folate), HIV co-infection, poverty and limited 
access to effective primary health care and 
emergency obstetric services exacerbate the 
8
impact of malaria in pregnancy . Women are 
particular at risk of cerebral malaria, 
hypoglycemia, pulmonary edema and severe 
hemolytic anemia. Fetal and perinatal loss has 
been documented to be as high as 60-70% in 
3
non-immune women with malaria . These 
complications are commoner in primigravidae 
3,4
than multigravidae .
The renewed interest in protecting and 
promoting both maternal and child health has led 
to the three pronged approach of tackling 
malaria in pregnancy, namely: intermittent 
preventive treatment of malaria using an 
effective antimalarial drug to address the heavy 
burden of asymptomatic infections among 
pregnant women living in areas of moderate to 
high transmission of Plasmodium falciparum; 
the use of insecticide treated nets by all pregnant 
women and effective case management of 
10
malaria illness and anaemia.  In 1986, World 
Health Organization recommended that 
pregnant women living in malaria endemic areas 
receive chemoprophylaxis with a safe and 
effective antimalarial drug as part of routine 
11
antenatal care . Although this recommendation 
was widely adopted as policy across Sub-
Saharan Africa, program implementation was 
often poor or non-existent especially in East-
Africa. In 2000, the WHO Expert committee on 
malaria recommended that malaria control 
during pregnancy should emphasize a 
preventive package that included either 
intermit tent  prevent ive t reatment  or  
12
chemoprophylaxis . 
Intermittent Preventive Treatment (IPT) 
involves the administration of therapeutic doses 
9
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of an antimalarial drug to a population at risk 
whether or not they are known to be infected, at 
specific point intervals usually with the aim of 
13reducing morbidity and mortality . In 2002, 
WHO developed a strategic framework for the 
control of malaria during pregnancy in Africa. 
The document recommends that pregnant 
women receive at least two doses of 
Sulphadoxine-Pyrimethamine (SP) as 
intermittent preventive treatment during the 
second and third trimesters during the routine 
antenatal visit while chemoprophylaxis is no 
longer recommended for a no of reasons 
including the difficulty in the delivery of this 
strategy, poor adherence with weekly drug 
dosing and rising rate of resistance to most of 
the chemoprophylaxis regimens including 
14chloroquine . Recently, intermittent preventive 
treatment (IPT) has been shown to be better 
than malarial chemoprophylaxis and has 
3,4,13replaced it .
The objective of this study was to 
determine the influence of the use of 
intermittent preventive treatment of malaria 
with sulphadoxine-pyrimethamine during 
pregnancy on the prevalence of malaria in 
pregnancy and the outcome of pregnancy. The 
outcome of this would help to strengthen the use 
of IPT by the pregnant women during routine 
antenatal care in University Teaching Hospital, 
Ado-Ekiti.
MATERIALS AND METHODS
The study was a prospective descriptive 
cross-sectional study carried out at the 
maternity department of the University 
Teaching Hospital, Ado-Ekiti, Nigeria over a 
period of 13 months. Ado-Ekiti is the capital 
city of Ekiti-State located in the south-western 
part of Nigeria with a population of about 
3,500,000. The people of Ado-Ekiti are mainly 
Yoruba ethnic group and the city is the 
commercial nerve centre for farm produce from 
the neighboring towns and villages of the state, 
an agrarian state. The University Teaching 
Hospital, Ado-Ekiti is an emerging teaching 
hospital that was established about two years 
ago and it serves as a referral centre for all the 
specialist and general hospitals in the state. 
About five thousand women booked annually 
for antenatal care in the hospital with an average 
of about 80 attendees at each of the two 
consultants' clinic day in a week.
The tool for data collection from the 
r e s p o n d e n t s  w a s  a  s e m i - s t r u c t u r e d  
questionnaire which was administered to 
women in the lying in ward of the maternity 
department who were booked in the hospital, 
attended at least two antenatal clinic visits and 
delivered in the hospital. The questionnaires 
were administered by house-officers and 
registrars in the department who had been 
trained on how to do so.  The research 
instrument had three sections: the first section 
elicited information about the socio-
demographic characteristics of the respondents; 
the second section inquired about the current 
antenatal history and the third section about the 
labour history and the neonatal outcome. About 
4200 women who met the inclusion criteria were 
recruited. The data collected were entered 
and analyzed with the use of Statistical Package 
for Social Sciences (SPSS) software, version 15. 
The results were summarized using relevant 
descriptive statistics (such as means) and 
presented using frequency tables and 
percentages. The association between discrete 
variables was tested using chi-square test. 
Statistical significance was accepted at p value < 
0.05. 
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RESULTS
About 4200 women recruited for the study 
participated by filling the questionnaires giving 
a response rate of 100%.
Table 1 showed that 3136 (74.7%) pregnant 
women received intermittent preventive 
treatment while 1064 (25.3%) did not receive 
this. 2800 women (66.7%) were Christians 
while 1400 women (33.3%) were Muslims. 
2716 (64.7%) of the women were Yoruba, 812 
(19.3%) were Igbo and 672 (16%) were Hausas. 
504 (12%) pregnant women had no formal 
education or primary school education while 
1092 (26%) and 2604 (62%) women had 
secondary and tertiary education respectively. 
868 (20.7%) women were nulliparous and 3332 
(79.3%) were multiparous women. 2744 
(65.3%) women belonged to the upper social 
class, 756 (18%) women were in the middle 
social class and 700 (16.7%) women belonged 
to the lower social class.
Of the women that received the IPT drug, 727 
(23.1%) of them were nulliparous while 2409 
(76.9%) were multiparous. 700 (22.3%) of 
them received one dose of the drug while 2436 
(77.7%) received 2 doses of the IPT drug. 
The age range of the respondents was between 
19-41years with a mean age of 31.19± 
4.882years, the parity of the women was para 0-
4 with a mean parity of 1.61±1.095, their 
gestational age at booking ranged from 9-
34weeks with a mean gestational age of 
21.13±4.562weeks and the gestational at 
presentation in labor was between 32-43 weeks 
with the age at 38.83±1.548. The duration of 
labor was between 5-12hours with a mean 
duration of 8.63±1.53 and the birth weight of 
their babies ranged from 2.2-4.4 with a mean 
birth weight of 3.277±0.4019.                                                                                                                    
Table 2 showed the comparison of the 
characteristics between the women who 
received intermittent preventive treatment and 
the women who did not receive the treatment.
 There was no significant difference in the mean 
age, mean gestational age at booking and 
delivery between the women that used IPT drug 
and those who didn't use but there was 
significant difference in the mean parity, birth 
weight and duration of labor of the women.
More women who are multiparous with higher 
educational status and social class and of Yoruba 
race used IPT during pregnancy in this study and 
this was found to be statistically significant. 
However, even though more women who are 
Christians used the IPT during pregnancy, it was 
not statistically significant.
Table 3 showed the incidence of malaria in 
pregnancy among the women who had IPT and 
those who did not have IPT.
There was a higher incidence of malaria in 
pregnancy among women who did not receive 
intermittent preventive treatment of malaria 
compared to women who used it and this was 
statistically significant.
Table 4 showed the incidence of malaria in 
pregnancy among the women who had a single 
dose of IPT and those women who had double 
dose of IPT.
Among the women who used IPT and had 
malaria in pregnancy, the incidence of malaria 
was higher in those who had a single dose of the 
drug compared to those had two doses and this 
was statistically significant.
Table 5 showed the outcome of pregnancy 
among the women who had IPT and those who 
did not have during pregnancy.
11
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The mean gestational age at presentation in 
labor were comparable between the women 
who received IPT and those women who did not 
receive even though the women who received 
IPT presented at a higher gestational age in 
labor, however this was not statistically 
significant.
The duration of labor was higher in women who 
did not use IPT and the birth weight of babies 
was also lower in them, this was statistically 
significant.
TABLE 1 showing the sociodemographic 
characteristics of the pregnant women involved 
in the study.














































Upper (I & II) 2744 65.3
Middle 756 18.0
Lower (IV & V) 700 16.7
TABLE 2 showing the comparison of 
demographic characteristics and obstetric 
outcome between pregnant women who used 
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Duration of 
labor(hrs)
8.6±1.491 8.7±1.634 0.011       S
GA= Gestational age (weeks); NS= Not Significant; S= Significant
Characteristics Yes IPT No IPT X
2
df     P value
n= 3136 % n= 1064 %
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Muslim 1064 76.0 336 24.0
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III 530 70.1 226 29.9
IV & V 478 68.3 222 21.7
Parity of the 
women 46.844     1      
0.0001
(S)
Nulliparous 727 23.1 142 13.3
Multiparous 2409 76.9 922 76.7
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DISCUSSION
The study revealed that more than two-
thirds of the pregnant women studied had 
access to intermittent preventive treatment of 
malaria and also that among the women 
attending the antenatal clinic that received the 
IPT, more than two-third of them took the 
recommended dose of the IPT. The high 
coverage recorded in this study is similar to that 
14 15
reported by Takem et al  and Falade et al  but 
higher than that in previous hospital based 
16 17
studies by Nganda et al  and Van Ejik et al . 
This higher coverage was due to the fact that the 
study was done in the antenatal clinic where the 
IPT drug was being distributed. It also showed 
that the program implementation is improving 
gradually over time.
There was a low prevalence of malaria 
among women who used IPT compared to those 
who did not use it and this was statistically 
significant. Even among the women that took 
IPT, those that took two doses of IPT experience 
a lower prevalence of malaria compared to those 
who took one of the drug. This demonstrates the 
efficacy of the IPT drug in improving the 
outcome of pregnancy. This is comparable to 
14 18reports by Takem et al  and Mbonye et al  who 
reported a reduction in the prevalence of 
peripheral parasitaemia and parasite density 
among women of all parities.
The increased use of intermittent 
preventive treatment with increasing level of 
education found in this study is not surprising 
since those with higher educational status are 
more health conscious and can easily apply 
health education programs to their daily living. 
This finding is consistent with report in previous 
14 19studies by Takem et al and Marchant et al . 
Women in the higher social class and parity were 
also associated with greater tendency to use the 
IPT drug. This is because women in that class 
tend to know and appreciate the benefits of the 
preventive measures against malaria in 
pregnancy like the use of insecticide treated nets 
and IPT amongst others. The multiparous  
women comply more with antenatal instructions 
including the use of prescribed drugs compared 
to the primigravid women since they would have 
discovered the benefits associated with these 
drugs in their previous pregnancies (experienced 
they say is the best teacher). This is similar to 
19finding earlier reported by Marchant et al  but 
14not consistent with that of Takem et al  who 
reported that the effect of socioeconomic status 
on IPT use was close to null in their studies.
TABLE 3 showed the prevalence of malaria in 
pregnancy among women who had IPT and 
those who did not have IPT.                                                             
Characteristics Yes IPT Use No IPT Use X
2









Treated for Malaria ?
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0.0001
(S)









TABLE 4 showed the prevalence of malaria in 
pregnancy among women who had single dose 
of IPT and those who had double dose of IPT.
Characteristics Single dose IPT Double dose IPT X
2










                                                    
32.114     1      
0.0001
(S)









TABLE 5 showed the outcome of pregnancy 
among women who had IPT and those who did 
not have IPT.
Mean GA at delivery 38.85±1.459 38.76±1.784 0.122       NS







0.0001     S
Women who received IPT during 
pregnancy had better outcome of their 
pregnancy. Low birth weight and prematurity 
are the greatest risk factors for neonatal 
mortality and a major contribution to infant 
15mortality . In this study, babies born to mothers 
who received IPT-SP on the average weighed 
more than babies born to women who did not 
received the drug. They also had shorter 
duration of labor which reduced the length of 
time the babies had to be exposed to the stress of 
labor. The birth weight of babies in this study 
may not only be attributed to the low prevalence 
of malaria in pregnancy in them since other 
factors such as socio-economic level may also 
play a role but this was statistically significant. 
15This is similar to reports from Falade et al , 
18 20Mbonye et al  and Shulman et al . 
High educational status and gravidity 
are associated with the use of intermittent 
preventive treatment among pregnant women 
attending antenatal clinic in this study and that 
use of Sulphadoxine-Pyrimethamine as 
intermittent preventive treatment of malaria 
during pregnancy has been accepted by women 
as a malaria control strategy in pregnancy. 
However, much work still need to be done to 
improve the uptake of the drug especially 
among the pregnant women who are of low 
educational status and low parity, who 
incidentally had a higher prevalence of malaria 
in this study and to ensure that all pregnant 
women received the recommended two doses 
of the IPT during pregnancy.
The results from the study also showed 
that intermittent preventive treatment of 
malaria during pregnancy with Sulphadoxine-
Pyrimethamine is beneficial in improving 
pregnancy outcome and is widely used by the 
pregnant women attending antenatal clinic 
13
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though not optimal. Therefore, health education 
programs for pregnant women in this area 
should be intensified in women of low 
educational status and low parity to improve the 
uptake among them. Direct observation therapy 
system (DOTS) can also be employed in which 
the pregnant women would be asked to take the 
drug under the observation of the nurses in the 
antenatal clinic. This would help in improving 
the compliance rate since some women may get 
the drug and not use it.
Government should be encouraged to 
make the drug available in the various antenatal 
clinics to be distributed to pregnant women free 
or at subsidized rate as part of efforts at 
improving maternal and child health in order to 
achieve the millennium development goals 
(MDGS) 4 and 5.
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